<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133-vaccines-07-00053">
 <label>133.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Pan</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ouyang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <article-title>Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F (abâ€™) 2 in mice</article-title>
  <source>Respir. Res.</source>
  <year>2006</year>
  <volume>7</volume>
  <fpage>43</fpage>
  <pub-id pub-id-type="doi">10.1186/1465-9921-7-43</pub-id>
  <pub-id pub-id-type="pmid">16553963</pub-id>
 </element-citation>
</ref>
